Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 15;3(4):732-6.
doi: 10.3889/oamjms.2015.111. Epub 2015 Oct 29.

Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment

Dafina Janevska  1 , Viktorija Chaloska-Ivanova  1 , Vlado Janevski  2
Affiliations
Review

Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment

Dafina Janevska et al. Open Access Maced J Med Sci. .

Abstract

Hepatocellular carcinoma (HCC) is the most often primary cancer of the liver and is one if the leading cause of cancer-related death worldwide. The incidence of HCC has geographic distribution with the highest levels in countries with developing economies. Patients with hepatocellular carcinoma have poor prognosis despite the achievements in surgery techniques and other therapeutic procedures and it is a reason why continuous attention should be paid to this issue. This article provides an overview of this disease based on an extensive review of relevant literature. The article summarizes the current risk factors, diagnosis, staging and the management of HCC.

Keywords: diagnosis; hepatocellular carcinoma; management; review article; risk factors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Estimated Liver Cancer Incidence Worldwide in 2012: Men (http://globocan.iarc.fr/old/FactSheets/cancers/liver-new.asp)
Figure 2
Figure 2
Estimated Liver Cancer Incidence Worldwide in 2012: Women (http://globocan.iarc.fr/old/FactSheets/cancers/liver-new.asp)
Figure 3
Figure 3
Barcelona Clinic Liver Cancer (BCLC) classification. *PST – Performance Status Test.
Figure 4
Figure 4
Performance status.
Figure 5
Figure 5
Child-Turcotte-Pugh score.
See this image and copyright information in PMC

References

    1. El-Serag HB. Hepatocellular Carcinoma. N Engl J Med. 2011;365:1118–27. http://dx.doi.org/10.1056/NEJMra1001683 . PMid:21992124. - PubMed
    1. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials. Annals of Oncology. 1997;8:117–136. http://dx.doi.org/10.1023/A:1008285123736 . PMid:9093719. - PubMed
    1. El-Serag HB, Rudolph KL. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterology. 2007;132:2557–2576. http://dx.doi.org/10.1053/j.gastro.2007.04.061 . PMid:17570226. - PubMed
    1. Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: Part I. Diagnosis and evaluation. Am Fam Physician. 2006;74:756–762. PMid:16970019. - PubMed
    1. Sanyal AJ, Yoon SK, Lencioni R. The Etiology of Hepatocellular Carcinoma and Consequences for Treatment. The Oncologist. 2010;15(suppl 4):14–22. http://dx.doi.org/10.1634/theoncologist.2010-S4-14 . PMid:21115577. - PubMed